| 今开：0.1328 | 昨收：0.1301 |
| 最高：0.135 | 最低：0.126 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：5930929.0 |
Avenue Therapeutics(ATXI)01-25 05:15
$Avenue Therapeutics(ATXI)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001104659-24-006250 Act: 33 Size: 342 KB 网页链接查看全文
Avenue Therapeutics(ATXI)02-24 05:25
$Avenue Therapeutics(ATXI)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001104659-24-027037 Act: 34 Size: 207 KB 网页链接查看全文
Avenue Therapeutics(ATXI)03-19 04:25
$Avenue Therapeutics(ATXI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-24-008294 Act: 34 Size: 7 MB 网页链接查看全文
Avenue Therapeutics(ATXI)03-15 19:25
$Avenue Therapeutics(ATXI)$ 8-K Current report, item 8.01 Accession Number: 0001104659-24-034774 Act: 34 Size: 204 KB 网页链接查看全文
Avenue Therapeutics(ATXI)03-19 05:05
$Avenue Therapeutics(ATXI)$ DEF 14C Other definitive information statements Accession Number: 0001104659-24-035578 Act: 34 Size: 112 KB 网页链接查看全文
Avenue Therapeutics(ATXI)04-18 04:15
$Avenue Therapeutics(ATXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-048303 Size: 5 KB 网页链接查看全文
Avenue Therapeutics(ATXI)04-18 04:15
$Avenue Therapeutics(ATXI)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-048307 Act: 34 Size: 52 KB 网页链接查看全文
Avenue Therapeutics(ATXI)03-19 04:15
$Avenue Therapeutics(ATXI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-035544 Act: 34 Size: 287 KB 网页链接查看全文
Avenue Therapeutics(ATXI)01-29 21:05
$Avenue Therapeutics(ATXI)$ DEF 14C Other definitive information statements Accession Number: 0001104659-24-007466 Act: 34 Size: 142 KB 网页链接查看全文
产业链观察2023-03-02 21:25
#药闻简讯# $Avenue Therapeutics(ATXI)$ 与AnnJi制药公司达成了AJ201的独家许可协议，AJ201是一种一流的临床资产，目前正在美国进行1b/2a期研究，用于治疗脊柱和球状肌肉萎缩症，也称为肯尼迪病。
根据条款，AnnJi将获得300万美元的预付款，并有权获得未来的开发、监管和商业化里程碑付款，以...查看全文
港美情报站2022-09-23 18:02
与葛兰素史克签大单！$Spero治疗(SPRO)$ 荣登妖股涨幅榜榜首
医药股历来是妖股集中营，昨日#美股# 涨幅前二的#妖股# 都是生物医药行业。昨日妖股涨幅榜榜首是SPRO，盘中最大涨幅接近300%，收盘涨幅也有167%。
消息面上，昨日，葛兰素史克和Spero Therapeutics已就tebipenem pivoxil hydrob...查看全文
格隆汇4月18日丨Avenue Therapeutics盘前涨15.65%，报1.33美元。Avenue Therapeutics周一表示，3月9日与美国FDA就开发用于治疗术后疼痛的静脉注射曲马多(IV Tramadol)举行的官方纪要表明，该机构在拟议研究方案... 网页链接
$Avenue Therapeutics(ATXI)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001104659-23-107251 Act: 34 Size: 24 MB 网页链接
$Avenue Therapeutics(ATXI)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001104659-23-106484 Act: 34 Size: 6 MB 网页链接
$Avenue Therapeutics(ATXI)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-23-105416 Act: 33 Size: 743 KB 网页链接
$Avenue Therapeutics(ATXI)$ 8-K Current report, item 3.01 Accession Number: 0001104659-23-104769 Act: 34 Size: 198 KB 网页链接
$Avenue Therapeutics(ATXI)$ 8-K Current report, item 8.01 Accession Number: 0001104659-23-104272 Act: 34 Size: 197 KB 网页链接
$Avenue Therapeutics(ATXI)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-23-101665 Act: 33 Size: 556 KB 网页链接
$Avenue Therapeutics(ATXI)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-23-101658 Act: 34 Size: 52 KB 网页链接
$Avenue Therapeutics(ATXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-23-025643 Size: 4 KB 网页链接
$Avenue Therapeutics(ATXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-23-025640 Size: 4 KB 网页链接
$Avenue Therapeutics(ATXI)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001104659-23-099306 Act: 34 Size: 235 KB 网页链接